OpenAlex
PricingAboutJobs
Log inGet started
Work

TMB or not TMB as a biomarker: That is the question

HTML

Year: 2021
Type: review
Source: Critical Reviews in Oncology/Hematology
DOI: 10.1016/j.critrevonc.2021.103374
Authors: Alfredo Addeo, Alex Friedlaender, Giuseppe L. Banna, Glen J. Weiss
Institutions: University Hospital of Geneva, Générale-Beaulieu Clinic, Portsmouth Hospitals NHS Trust
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: tumor mutational burden, immune checkpoint inhibitors, predictive biomarkers, pembrolizumab, pan-cancer biomarker, PD-L1 expression, neoantigens, non-small cell lung cancer, melanoma, overall survival, KEYNOTE-158, patient selection
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3164167181
FWCI: 5.48
Cites: 68
Cited by: 245
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security